- HHS defers $1B+ in Medicaid funds to Minnesota, California
- Pennsylvania dentist retires after 55 years of service
- UHS-owned behavioral health facility faces child sexual abuse lawsuit
- Complexity no longer decides where orthopedics belongs
- Radiology Partners names 2 clinical leaders
- Illinois Legislature approves changes to teledentistry laws
- Amazon’s pay for 8 health tech jobs
- Delaware Legislature passes bill expanding scope of practice for hygienists
- HHS defers $1B+ in Medicaid funds to Minnesota, California
- North Star Health Alliance’s ASC closure heads to public hearing
- Texas safety-net behavioral healthcare provider secures $18M amid financial shortfall
- Median pay for 42 hospital jobs
- Care New England executive heads to Connecticut Children’s
- Iowa board sanctions MercyOne pharmacy after drug diversion
- 56 health systems with strong finances
- How $300K in student debt can change dental career paths
- Cleveland Clinic receives $25M from Cleveland Browns owner
- Physician practices drive 2026 healthcare bankruptcies: 6 notes
- UNC Health dismisses 340B underpayment lawsuits targeting Humana
- 5 medical device recalls to know
- Apple must pay health tech company $634M, judge says
- ECU Health taps new ASC president
- Canada DSO enters US market
- Beacon Behavioral Partners enters Midwest
- 5 orthopedic, spine lawsuits to know: Q2 2026
- House reauthorizes Action for Dental Health Act: 5 notes
- Georgia to build $409M forensic psychiatric hospital
- Smile Doctors appoints former CVS Health exec as CFO
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Optum-backed physician group inks deal with California health system
- 5 health systems, hospitals expanding GI services
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- 13 behavioral healthcare M&A deals in 2026
- Remarks to the Small Business Capital Formation Advisory Committee
- New Jersey behavioral health company acquires independent medical examination provider
- Sanofi continues tweaks to executive roster as new CEO Garijo settles in
- Coffee May Lower Your Heart Disease Risk, But How Much Is Safe?
- Alembic site slapped with FDA warning letter over patient consent concerns
- Trump admin pausing over $1B in Medicaid payments to California, Minnesota
- Lilly, BMS aerospace partner Redwire opens new site in Indiana
- The Best Surgery For Pelvic Organ Prolapse?
- Novartis CEO brushes off oral PCSK9 competition as Leqvio drives Q2 growth
- Gait Training Can Help Knee Arthritis
- More Than Half Of US Adults Should Be Offered Statins, Study Says
- Karoo Health banks $16.2M series A to advance value-based cardiology platform
- Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages
- Doctors 'Cringe' At Possibility Of Documenting Which Medicaid Enrollees Are Too Sick to Work
- Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads
- Leadership Vacuum: Agencies in New York and Beyond Pass the Buck on Opioid Cash Oversight
- A Deloitte-Run System Denied Medicaid Benefits for Michigan’s Disabled. Now Trump’s Law Piles On.
- Severely Ill Prisoners Granted Early Release Are Left Stuck Behind Bars
- Gilead, Merck’s phase 3 data back first weekly HIV pill
- J&J’s Tremfya remains on top in Q2 pharma ad spending league as overall outlay drops
- The billing gap leaving ASC patients stuck in limbo
- UMass Memorial behavioral health provider plans phased closure, layoffs grow to 231
- 10 states investing in behavioral healthcare
- Median pay for cardiologists nears $500K: Breakdown by state
- How much are physician signing bonuses?
- Oral Surgery Partners expands network in three states
- Imagen Dental Partners adds Texas practice
- Premier Care Dental Management acquires Massachusetts practice
- DHS decouples duration of some visas from training program length
- AI emerges as top healthcare IT investment globally, KLAS finds
- Healthcare affordability, fraud are key issues for voters heading into 2026 midterms
- FDA: Iceberg Lettuce Recall Stands After False Positive For Cyclospora
- Clover Health reveals data breach in SEC filing
- Why Do So Many Women Miss The Signs Of Perimenopause?
- J&J, Time link up to spotlight healthcare leadership with Healthcare Champion of the Year award
- Health systems need to prepare for an AI-driven reinvention of work, Abundant Alliance's Eric Langshur says
- Healthcare bankruptcy volume 'stabilizes' in H1, though more practices are falling under
- Sanofi survey uncovers Type 1 diabetes misconceptions and screening gaps
- Samsung Biologics spreads wings with proposed $1.8B acquisition of Swiss CDMO PolyPeptide
- Why Legend Biotech stock fell 10% despite record Carvykti sales
- Virtual Therapy Sessions Improve Lives Of Kids With Lupus
- More Evidence Links Sleep Apnea To Dementia And Memory Loss
- Study Links GLP-1 Medications To Rare Vision Issue
- Gut Bacteria May Hold Key To Preventing Severe Peanut Allergies
- Tempus buys out cancer genomics partner Personalis in $1.5 billion deal
- Trump's CDC Nominee Praises Vaccines, Without Vowing Independence From RFK Jr.
- Pregnant Woman’s Roadside Death Triggers Push To Reopen Mississippi Delta Hospital
- Doctors ‘Cringe’ at Possibility of Documenting Which Medicaid Enrollees Too Sick To Work
- Violence Repeatedly Erupts at Dementia Care Facilities Despite Warnings, Inspections Show
- Journalists Dig Into HHS’ Covid Injury List, ACA Sign-Ups, and Telehealth
- CDC Warns Of Parasite Outbreak Tied To Taco Bell Lettuce In 5 States
- Actress Rebel Wilson pairs GLP-1s and healthy habits to lose weight 'for keeps' in new Noom campaign
- The Best Vegetables For Your Heart May Depend On Your Sex
- UnitedHealthcare exec says 'ineffective' No Surprises Act IDR process demands reform
- Federal judge temporarily blocks key provisions of final ACA exchange rule days before set to take effect
- Op-ed: Accountability and access must coexist in hospice care
- Novartis gains full FDA nod for Fabhalta in kidney disorder IgAN
- Novo, Alvotech face continued scrutiny at plants tied to recent FDA rejections
- Coalition files lawsuit against Trump administration over Teen Pregnancy Prevention Program funding cuts
- One Type Of ADHD Med May Affect Kids' Weight
- Poll: Many Older Americans Unaware Of 988 Suicide Help Line
- Black Americans Born Abroad Have Lower Odds For Stroke, Study Finds
- A Hidden Influence On Teen Girls' Emotions: Testosterone
- Fierce Pharma Asia—GSK, Merck ADCs’ trial wins; AZ’s $1.5B EGFR buy; Biotechs’ new patent tricks
- A Sales Tax On Doctor Visits And Medicine? In Missouri, Some Worry
- Insurers Hedge on Trump-Backed Pledge To Improve Denials Process
- Watch: ‘Robust’ Primary Care, Transparency Top Employers’ Reform Wish List
- Foundation Medicine launches 'Quality First' initiative to stand out in cancer testing market
- Big Pharma’s Big Brand: Novartis reconnects to its past as it moves forward
- Trump’s CDC Nominee Praises Vaccines, Without Vowing Independence From Kennedy
- Lights, camera, action: CG Life to spotlight rare disease in dedicated film festival
- GE HealthCare, Catholic Health strike 10-year, $500M technology partnership
- Thriveworks launches insight dashboard for referring providers
- Why Commercial Evidence Is the Next Breakthrough in Pharma Intelligence
- CMS proposal to block third-party vendors will upend remote monitoring services, health tech leaders say
- FDA Clears First Cholesterol Pill, Lipfendra, To Rival Costly Injections
- Statement on Regulation E-Delivery
- Weekly Rundown: Novant Health rolls out new virtual primary care model; GW RhythmX launches Pulse on Microsoft Marketplace
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- One Of The Largest Epidural Studies Ever Delivers Reassuring News For Parents
- Coalition for Health AI launches implementation initiative for public health agencies
- Could A Vaccine Prevent Pancreatic Cancer In Those At High Risk?
- Heatwaves During Pregnancy Could Affect Baby's Brain Development, Study Suggests
- Brain 'Microstimulation' Works Long-Term To Restore Sense Of Touch After Spinal Cord Injury
- 'Night Owls' At Risk Of Wider Waistlines, Unhealthy Hearts
- Facing Funding Losses, States Call Out Big Businesses With Employees On Medicaid
- UnitedHealth Group to stay 'restless' even after topping investor's Q2 expectations, CEO says
- Senate HELP committee grills CDC nominee Erica Schwartz on vaccine policy, resistance to political interference
- West Tennessee Healthcare expands critical care support through eICU Program in partnership with Philips and hellocare.ai
- Operating at the speed of science: The new medical affairs playbook
- Why modern clinical trials need a finance-first strategy
- Wildfire Smoke Puts Millions At Risk Across Midwest, Northeast
- Are Microplastics Linked To Higher Heart Attack Risk?
- Impulsivity In Third Grade Could Point To Future Struggles
- AI Can Create 'Ghosts' Of Lost Loved Ones, But Would You Want To Meet Them?
- Blood Test May Predict Alzheimer's Risk Up To 10 Years Before Symptoms Begin
- Knee Pain? Ragged Cartilage? Research Suggests Surgery's Not The Best Answer
- THC/CBD Combo Might Ease Agitation In Late-Stage Dementia
- Access: A key driver of non-opioid pain management adoption
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- Why clinician-led IT is the future of care
- Remarks before the American-Hellenic Chamber of Commerce
- CDMO trends reshaping biopharma manufacturing
- Close the Clinical Handoff Gap. Improve Post-Acute Outcomes.
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Regulatory tracker: Takeda's Qdenga becomes 1st dengue vaccine cleared in India
Michigan healthcare freedom community forum
The recent SCOTUS decision in United States v. Skrmetti, the case upholding Tennessee’s ban on adolescent transgender treatments, has Jonathan Turley examining the decline in America's expert class:
https://jonathanturley.org/2025/06/26/the-icarian-gene-the-rise-and-fall-of-the-expert-class/
The Icarian Gene: The Rise and Fall of the Expert ClassBy Jonathan Turley - June 26, 2025
The warning was stark. At issue was a privileged class that has long dictated policy despite countervailing public opinion. At issue, the luminary warned, is nothing short of democracy itself. No, it was not the continued rallies of Sen. Bernie Sanders (I., VT) to “fight oligarchy.” It was Justice Clarence Thomas rallying his colleagues to fight technocracy, or government by experts. He warned against allowing “elite sentiment” to “distort and stifle democratic debate.” Yet, the story is even more profound of an elite class which succumbed to the Icarian gene and fell to Earth due to hubris and excess.
In his concurrence in United States v. Skrmetti, a case upholding Tennessee’s ban on adolescent transgender treatments, Thomas called for his colleagues to stand against an “expert class” that has dictated both policy and legal conclusions in the United States.
The reference to “experts” is often used to insulate an opinion as self-evidently true on a given question when they speak as a group. It distinguishes the informed from the casual; the certifiably authoritative from the merely interested. Yet, what constitutes an “expert” can be little more than an advanced degree, and the “overwhelming opinion of experts” can be little more than groupthink.
Thomas warned his colleagues that “[t]here are particularly good reasons to question the expert class here, as recent revelations suggest that leading voices in this area have relied on questionable evidence, and have allowed ideology to influence their medical guidance.”
Indeed, those “good reasons” have become increasingly obvious to those outside of the Beltway. The public saw experts line up during the pandemic to support mandatory uses of surgical masks, shutting down schools, and requiring the ruinous six-foot rule of separation. Many of these rules were later found lacking in scientific support. At the same time, dissenting experts, including the signatories of the Great Barrington Declaration, were blacklisted, censored, or fired for challenging these views.
We have seen the same orthodoxy on issues ranging from gender dysphoria to COVID measures.
In his concurrence, Thomas lashed out at the virtual mantra in court papers and the media of an “overwhelming medical consensus” in favor of transitioning children. This is often cited as the conclusive judgment of experts as opposed to citizens who overwhelmingly oppose treatments for children, including castration or surgical removal of genitalia. Thomas insisted that “so-called experts have no license to countermand the ‘wisdom, fairness, or logic of legislative choices.’”
For decades, citizens largely identified the government with bringing modern approaches to programs eliminating long-standing social ills from poverty to illiteracy to inequality. Roughly 100 years ago, the New Deal of Franklin Delano Roosevelt transformed the government’s role in American life. A generation of experts brought new ideas of electrification, education, and economics to the country.
This veneration was furthered by Kennedy’s assemblage of “the best and the brightest” and Johnson’s “Great Society” reformers.
The courts later followed with greater and greater deference afforded to these experts, including the establishment of the “Chevron doctrine” insulating agency decisions from substantial judicial review. The Supreme Court ruled that courts were poorly equipped to second-guess the expertise of agency experts.
The Reagan Revolution challenged those assumptions. Reagan famously told voters that “the nine most terrifying words in the English language are: I’m from the Government, and I’m here to help.”
Over the years, the mystique took on a more menacing aspect for many in the country as they watched academic and scientific groups become more advocates than experts. There seemed to be a shift from making for a better life to making us better people through progressive social agendas.
The result has been a dramatic change in trust for higher education and, by extension, the supremacy of the expert class. According to Gallup, only a third of Americans today have great confidence in higher education and roughly the same number have little or no confidence. That is a drop of over twenty percent in the last ten years.
Other polling shows drops in the trust for state and local public health officials as well as the U.S. Centers for Disease Control and Prevention (CDC).
The decline of the expert class can be traced to the changes in higher education over the last couple of decades. As I discuss in my book The Indispensable Right, an orthodoxy has taken hold of most universities with a purging of conservative, libertarian, and dissenting faculty. Within these ideological echo chambers, appointments, publications, and grants often seem to turn on conclusions that favor political agendas.
Over the years, dissenting faculty members have been forced out of scientific and academic organizations for challenging preferred conclusions on subjects ranging from transgender transitions to COVID-19 protections to climate change. Some were barred from speaking at universities or blacklisted for their opposing views.
As shown during COVID, many of the exiled experts were ultimately proven correct in challenging the efficacy of surgical masks or the need to shut down our schools and businesses. Scientists moved like a herd of lemmings on the origin of the virus, crushing those who suggested that the most likely explanation is a lab leak (a position that federal agencies would later embrace).
Scientists have worked with the government in suppressing dissenting views. At the end of last year, The Wall Street. Journal released a report on how the Biden administration suppressed dissenting views supporting the lab leak theory, as dissenting scientists were blacklisted and targeted.
When experts within the Biden Administration found that the lab theory was the most likely explanation for COVID-19, they were told not to share their data publicly and were warned about being “off the reservation.”
British pediatrician Hilary Cass published a review for NHS England that cast doubt on gender-identity treatments for children and young people. The research reportedly led to an aggressive campaign by the World Professional Association for Transgender Health (WPATH) to suppress the results.
The gravitational pull of social agendas has overwhelmed not just scientific judgment but common sense. For example, there has been a push to treat gender as a socially constructed myth.
A University of Pittsburgh anthropology professor declared that you cannot tell the gender of an individual from their bones – a widely ridiculed assertion.
The editor-in-chief of Scientific American Laura Helmuth made her own contribution to gender ideology by tweeting out a statement with a 2017 article in Audubon Notebook stating “White-throated sparrows have four chromosomally distinct sexes that pair up in fascinating ways. P.S. Nature is amazing[.] P.P.S. Sex is not binary.”
Various experts cried fowl and noted that her point was ideologically driven and scientifically absurd. (Helmuth later resigned after posting a profanity-laden attack on social media calling Trump voters “fascists” and bigots).
In many cases, dissenting views on social or political issues are treated as disqualifying for any research.
At Cornell, professors signed a letter denouncing “informed commentary” critical of violent protests as racist.
In 2020, Harald Uhlig, the senior editor of the prestigious Journal of Political Economy and the Bruce Allen and Barbara Ritzenthaler Professor in Economics at the University of Chicago, criticized Black Lives Matter and the movement to defund the police. The response was a campaign to remove Uhlig from the Journal. Writers like economist Paul Krugman insisted that he was now “yet another privileged white man” attacking the”less fortunate.”
The University of Pittsburgh Medical Center removed Associate Professor of Medicine Norman Wang from his position as Program Director of the Electrophysiology Fellowship after he wrote an article in a peer-reviewed journal questioning the use of affirmative action in medical schools admissions. (Later, the Supreme Court would declare such use of race as unconstitutional race discrimination).
Another controversy arose in 2024 just before the Supreme Court considered access to mifepristone, one of two drugs used for abortions by mail. District Judge Matthew Kacsmaryk relied on two studies that showed harm from the use of the pill.
The Sage journal Health Services Research and Managerial Epidemiology was widely criticized by abortion advocates for publishing the studies. One month before the oral argument, the studies were conveniently retracted and a review published that found the conclusions “invalidated in whole or in part.”
Justices and judges will often take favorable studies as gospel in supporting their legal conclusions. In her dissent in the University of North Carolina affirmative action case, Justice Ketanji Brown Jackson triggered a controversy in citing a 2020 study from a friend-of-the-court brief by the Association of American Medical Colleges. Jackson claimed that race-based admissions “saves lives” because having a Black physician more than doubles the likelihood of the survival of high-risk Black babies. The claim of the brief and the flawed methodology of the study was shredded by critics.
The fact is that it is easy to produce near uniformity of experts since most universities now run from the left to the far left. The combination of biased hiring practices has left most departments with few or no conservative faculty members. As a result, the media can report that liberal positions are supported overwhelmingly by “experts.”
For example, it is now common for the media to report signed letters or petitions of law professors denouncing conservative positions or rulings. It rarely mentions that most law schools have only a couple of conservative faculty members. It is like getting a pro-papal petition from the College of Cardinals. Nevertheless, the coverage leaves the impression that opposing views on transgenderism, gun rights, or other subjects are absurd and rejected by virtually all “experts.”
Both the courts and the public, however, appear to be losing their awe for the expert class. The Supreme Court recently tossed the Chevron Doctrine and called for courts to resume their prior scrutiny of agency decisions.
None of this means that courts or the public should disregard science or experts. Indeed, many experts still follow core principles of unbiased inquiry and discourse. However, good science requires open inquiry and a diversity of viewpoints. Citizens are rejecting science by plebiscite, the self-authenticating petitions where academics purported to speak for an expert class.
The expert class lost the public when they replaced objectivity with orthodoxy. No matter how many experts claim that gender is a social myth, the public is not likely to dispense with reality. The rise and fall of the expert class is a story of the costs of arrogance and excess. Higher education has created a privileged class of social warriors who abandoned core principles of neutrality and objectivity in research. It is an Icarian generation of scholars who flew too close to the sun and fell to Earth in the eyes of the public.
Jonathan Turley is the Shapiro Professor of Public Interest Law at George Washington University where he teaches a course on the Supreme Court. He is the best-selling author of “The Indispensable Right: Free Speech in an Age of Rage” and the forthcoming Rage and the Republic: The Unfinished Story of the American Revolution (Simon & Schuster 2026).
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















